Home
Leadership
Science
- Senescence
- Diseases
Data
News
Partners
Contact

Intro Page

Home / Intro Page

About Us

SIWA Therapeutics is a privately held preclinical stage biotechnology company that has a monoclonal antibody that targets and destroys senescent cells.

Recent News

DR. THOMAS TANG JOINS SIWA THERAPEUTICS SCIENTIFIC ADVISORY BOARD
Third Annual Healthspan Extension Policy and Regulation Workshop
Second Annual Healthspan Extension Policy and Regulation Workshop

JOIN OUR MAILING LIST

Navigation

Home

Leadership

Science

Data

News

Partners

Contact